Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
US Stock MarketDetailed Quotes
KYMR Kymera Therapeutics
- 35.280
- +0.730+2.11%
Close May 2 16:00 ET
- 35.280
- 0.0000.00%
Post 20:01 ET
2.30BMarket Cap-11.84P/E (TTM)
35.980High33.950Low640.38KVolume33.950Open34.550Pre Close22.74MTurnover1.49%Turnover RatioLossP/E (Static)65.12MShares53.27052wk High2.75P/B1.52BFloat Cap19.44552wk Low--Dividend TTM42.99MShs Float91.920Historical High--Div YieldTTM5.88%Amplitude9.600Historical Low35.503Avg Price1Lot Size
Kymera Therapeutics News
Kymera Therapeutics | SCHEDULE 13G/A: Others
Kymera Therapeutics | ARS: Annual Report to Security Holders
Kymera Therapeutics | DEFA14A: Others
Kymera Therapeutics | DEF 14A: Definitive information statements
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Goodman Noah
Kymera Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Goodman Noah
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs Bruce N.
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chiniara Ellen
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs Bruce N.
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chadwick Jeremy G
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mainolfi Nello
Kymera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Kymera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Kymera Therapeutics | 8-K: Current report
Kymera Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kymera Therapeutics | 10-K: FY2024 Annual Report
Kymera Therapeutics | 8-K: Kymera Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
Kymera Therapeutics | SCHEDULE 13G/A: Others
Kymera Therapeutics | 8-K: Current report
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mainolfi Nello
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now